RT Journal Article
SR Electronic
T1 Cetuximab (Erbitux)
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 626
OP 627
DO 10.3174/ajnr.A2054
VO 31
IS 4
A1 Bou-Assaly, W.
A1 Mukherji, S.
YR 2010
UL http://www.ajnr.org/content/31/4/626.abstract
AB SUMMARY: Cetuximab, a recombinant chimeric monoclonal antibody, has been successfully used in the treatment of the head and neck and colorectal cancers. We present a review of its mechanism of action, indications, side effects and economic issues, accompanied by a clinical example from our institution. EGFRepidermal growth factor receptorFDAUS Food and Drug AdministrationHERhuman epidermal growth factor receptorSCCsquamous cell carcinomaSCCHNSCC of the head and neck